Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?

Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?

Malignant Pleural Mesothelioma (MPM) is a rare neoplasm that is typically diagnosed in a locally advanced stage, making it not eligible for radical surgery and requiring systemic treatment. Chemotherapy with platinum compounds and pemetrexed has been the only approved standard of care for approximat...

Full description

Bibliographic Details
Main Authors: Federica Borea, Marika A. Franczak, Maria Garcia, Matteo Perrino, Nadia Cordua, Ryszard T. Smolenski, Godefridus J. Peters, Rafal Dziadziuszko, Armando Santoro, Paolo A. Zucali, Elisa Giovannetti
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
malignant pleural mesothelioma
target therapy
anti-angiogenic drugs
growth factors
mTOR
CDKN2A
Online Access:https://www.mdpi.com/1422-0067/24/11/9165

Internet

https://www.mdpi.com/1422-0067/24/11/9165

Similar Items